Brief: Mabion Fulfills Condition For Deal With WPD Pharmaceuticals
19/05/2025 13:27
May 19 (Reuters) - Mabion SA MABP.WA: FULFILLS CONDITION FOR DEAL WITH WPD PHARMACEUTICALS AGREEMENT FOR ANALYTICAL METHOD DEVELOPMENT SERVICES NOW EFFECTIVE Source text: nEM5vWFnqa Further company coverage: MABP.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects